「for」の検索結果
118件：111～115件目を表示
-
お知らせ | 千寿製薬株式会社
August 20, 2026 Senju initiated Phase III Clinical Trials in Japan for "SJP-0049" for the treatment of Allergic Conjunctivitis（PDF） June 1, 2026 Launch of Distribution of 3in1Smart and SPM-7...
https://www.senju.co.jp/english/news/ -
Milestones in Our History | About Senju | SENJU Pharmaceutical
ished the company in Tennoji-ku, Osaka with start-up capital of 195,000 yen. July Injection Product for Neutropenia, "PANILTIN", sales launched 1949 February Reishin Tanimura became the Pres...
https://www.senju.co.jp/english/about/history.html -
Research and Development System | Research & Development | SENJU Pharmaceutica
All things in nature have a reason for being.Today’s common sense may not be common sense tomorrow. At Senju Pharmaceutical, we are dedicated not only to our original R&D initiatives but also to R...
http://www.senju.co.jp/english/rd/about/ -
Product Development Policy | Research & Development | SENJU Pharmaceutica
timicrobial ophthalmic solutions, non-steroidal anti-inflammatory ophthalmic solutions, a treatment for vernal keratoconjunctivitis (an orphan disease), therapeutic drugs for glaucoma and ocular hyper...
http://www.senju.co.jp/english/rd/policy/ -
Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical
We contribute to society through the cause of the idea to serve the health of people since our formation, through providing the pharmaceutical products. As better corporate citizens, we promote the en...
http://www.senju.co.jp/english/about/csr.html